As a first-time investor, it can be daunting trying to figure out where to put your money. But don’t worry, we’ve got you covered. Join us as we cover different types of investments!

What are the most popular types of investments? | Get Rich Slow Club

Whilst none of us are the next Warren Buffett, we have the ability to "own a piece of America", as he often suggests. For this reason, we're sharing the 10 most most popular US stocks on Pearler. 

Check out Pearler's most popular US stocks

Think of community data as a compass: you can choose any stock you want, but our community keeps pointing in the same general direction - simple, diversified, and cheap ETFs. Let's take a look at the 10 most popular ETFs on Pearler.

These are Pearler's most popular ETFs

BeiGene Ltd (BGNE:US) Share Price | Pearler

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

The iShares S&P 500 ETF seeks to track the investment results of an index composed of large-capitalisation U.S. equities.

iShares S&P 500 Etf

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). These are mostly large and established Australian companies. It is a popular choice among passive individual investors who don't have the time or the expertise to actively invest in stocks.

Vanguard Australian Shares Index Etf

BlackRock Energy and Resources Trust (the Trust) is a non-diversified, closed-end management investment company. The Trust’s investment objective is to provide total return through a combination of current income and capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry. The Trust invests directly in such securities or synthetically through the use of derivatives. The Trust also invests up to 20% of its total assets in other United States and other non- United States investments. These investments include equity and debt securities of companies not engaged in the energy and natural resources industry. It invests in sectors, including oil, gas and consumable fuels, and metals and mining. The Trust's investment advisor is BlackRock Advisors, LLC.

BlackRock Energy and Resources Trust

Barings Global Short Duration High Yield Fund is a closed-end management investment company. The Fund's primary investment objective is to seek as high a level of current income as the advisor determines is consistent with capital preservation. It seeks capital appreciation as a secondary investment objective. It will invest at least 80% of its managed assets in bonds, loans and other income-producing instruments that are rated below investment grade. The Fund invests in various sectors, including aerospace and defense; automotive; beverage, food and tobacco; broadcasting and entertainment; buildings and real estate; cargo transport; chemicals, plastics and rubber; commercial services; containers, packaging and glass; diversified/conglomerate manufacturing; diversified/conglomerate service; electronics; finance; forest products and paper; healthcare, education and childcare, Internet, lodging, and hotels, motels, inns and gaming. Barings LLC serves as an investment advisor to the Fund.

BARINGS GL SH DUR HI YLD

BeiGene, Ltd. is a global biotechnology company. The Company is focused on developing and commercializing oncology medicines to improve treatment outcomes and expand access for patients worldwide. The Company has discovered and developed three approved medicines including, BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; tislelizumab, an anti-PD-1 antibody immunotherapy for the treatment of various solid tumor and blood cancers; and pamiparib, a selective small molecule inhibitor of PARP1 and PARP2. BRUKINSA is a second-generation small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) designed to maximize BTK occupancy and minimize off-target binding effects. It has obtained approvals to market BRUKINSA in the United States, China, the European Union, the United Kingdom, Canada and Australia. The Company has in-licensed the rights to distribute 13 approved medicines for the China market. 

BGNE

Buy

👑 Overview

📈

N/A

Annual Growth

🌏

0

Pearlers Invested

Key information

🔎 Fund Overview

Price History*

Unsure how much or often to invest?

🗓️ Investing frequency calculator

💵 Investing amount calculator

⏱️ Investing duration calculator

💵

6.50 AUD*

Purchase Fee

💼

N/A

Management Fee

💸

Want to know the long term costs?

Calculate the historic long term costs to hold your investments

Technical Info

$236.90

How our community is investing

0

N/A

N/A

N/A

N/A

BGNE investor breakdown

💵 Income of investors

👶 Age of investors

🙋 Legal gender of investors

$11.59 USD

Find Out More

$12.55 USD

Find Out More

Buy